Kangmei Pharmaceutical Co., Ltd. (SHA: 600518)
China flag China · Delayed Price · Currency is CNY
2.520
-0.140 (-5.26%)
Nov 13, 2024, 3:00 PM CST

Kangmei Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
773.511,0571,5072,419552.34501.2
Upgrade
Short-Term Investments
-----5.88
Upgrade
Trading Asset Securities
0.080.080.120.52--
Upgrade
Cash & Short-Term Investments
773.591,0571,5082,419552.34507.08
Upgrade
Cash Growth
-34.78%-29.91%-37.68%337.98%8.93%-72.37%
Upgrade
Accounts Receivable
2,3402,0952,0461,4602,4873,855
Upgrade
Other Receivables
690.11874.44888.791,0529,55910,618
Upgrade
Receivables
3,0302,9692,9352,51212,04614,473
Upgrade
Inventory
2,8862,6442,7513,1955,70931,408
Upgrade
Prepaid Expenses
-0.690-0.01-
Upgrade
Other Current Assets
319.93139.28190.85158.8234.39625.09
Upgrade
Total Current Assets
7,0106,8107,3848,28518,54147,013
Upgrade
Property, Plant & Equipment
3,7113,8754,1804,6429,60311,409
Upgrade
Long-Term Investments
1.161.151.39111.04
Upgrade
Goodwill
106.35106.35106.35106.3536.9181.2
Upgrade
Other Intangible Assets
465.12491.02529.79579.731,3092,022
Upgrade
Long-Term Deferred Tax Assets
97.53101.4896.9760.69240.96256.7
Upgrade
Long-Term Deferred Charges
61.2166.4786.71110.22111.57244.23
Upgrade
Other Long-Term Assets
2,7412,8292,7832,2693,4833,558
Upgrade
Total Assets
14,19414,28015,16916,05433,32664,586
Upgrade
Accounts Payable
2,5432,2562,5632,0153,7623,774
Upgrade
Accrued Expenses
62.64873.711,3281,1342,066934.9
Upgrade
Short-Term Debt
12.226.1425.6215.172,31512,811
Upgrade
Current Portion of Long-Term Debt
-----5,113
Upgrade
Current Portion of Leases
34.5440.7139.1236.89--
Upgrade
Current Income Taxes Payable
410.5424.7426.2140.5112.15125.79
Upgrade
Current Unearned Revenue
172.84159.89158.12193.85455.19-
Upgrade
Other Current Liabilities
1,6751,2981,3011,41114,5765,064
Upgrade
Total Current Liabilities
4,9114,6805,4424,94723,28627,823
Upgrade
Long-Term Debt
----19,41515,010
Upgrade
Long-Term Leases
169.19188.16199.13153.22--
Upgrade
Long-Term Unearned Revenue
591.85618.68653.98692.971,0351,103
Upgrade
Long-Term Deferred Tax Liabilities
43.8551.6855.53-0.050.08
Upgrade
Other Long-Term Liabilities
1,4021,6611,835293.02--
Upgrade
Total Liabilities
7,1187,2008,1856,08643,73643,935
Upgrade
Common Stock
13,86413,86413,86413,8644,9744,974
Upgrade
Additional Paid-In Capital
18,78318,78318,78318,78311,57611,553
Upgrade
Retained Earnings
-24,370-24,375-24,478-21,790-29,7061,368
Upgrade
Treasury Stock
-1,236-1,225-1,222-932.82-343.6-343.6
Upgrade
Comprehensive Income & Other
1.191.181.433.1-3.74-3.51
Upgrade
Total Common Equity
7,0427,0486,9489,927-13,50417,548
Upgrade
Minority Interest
33.9332.8935.4341.92126.47135.72
Upgrade
Shareholders' Equity
7,0767,0806,9849,968-10,41020,651
Upgrade
Total Liabilities & Equity
14,19414,28015,16916,05433,32664,586
Upgrade
Total Debt
215.93255.01263.87205.2921,73032,934
Upgrade
Net Cash (Debt)
557.66801.681,2442,214-21,178-32,427
Upgrade
Net Cash Growth
-39.14%-35.54%-43.82%---
Upgrade
Net Cash Per Share
0.040.080.090.16-1.53-6.57
Upgrade
Filing Date Shares Outstanding
13,86413,86413,86413,8644,9744,974
Upgrade
Total Common Shares Outstanding
13,86413,86413,86413,8644,9744,974
Upgrade
Working Capital
2,0992,1301,9423,338-4,74519,190
Upgrade
Book Value Per Share
0.510.510.500.72-2.713.53
Upgrade
Tangible Book Value
6,4706,4506,3129,240-14,84915,444
Upgrade
Tangible Book Value Per Share
0.470.470.460.67-2.993.11
Upgrade
Buildings
-5,2295,4015,6658,3597,039
Upgrade
Machinery
-820.08826.651,2062,7993,530
Upgrade
Construction In Progress
-210.56215.5263.651,6303,714
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.